A critical look at ocular allergy drugs

American Family Physician

Volumn 53, Issue 8, 1996, Pages 2637-2642

  Titi, Mark Joseph ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CROMOGLYCATE DISODIUM; KETOROLAC TROMETAMOL; LEVOCABASTINE; LODOXAMIDE TROMETAMOL; NAPHAZOLINE; TERFENADINE; UNCLASSIFIED DRUG; VASOCON A;

ALLERGIC CONJUNCTIVITIS; ARTICLE; CARDIOTOXICITY; DRUG EFFICACY; DRUG FORMULATION; DYSPNEA; EYE IRRITATION; EYELID EDEMA; GASTROINTESTINAL TOXICITY; HUMAN; HYPERTENSION; MYDRIASIS; PUNCTATE KERATITIS; RASH; TREATMENT PLANNING; VISUAL IMPAIRMENT;

ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CONJUNCTIVITIS, ALLERGIC; HISTAMINE H1 ANTAGONISTS; HUMANS; KETOROLAC TROMETHAMINE; OXAMIC ACID; PIPERIDINES; TOLMETIN; TROMETHAMINE;

EID: 0029946136     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Friedlander MH. Ocular allergy. In: Middleton E Jr, et al., eds. Allergy: principles and practice. 3d ed. St. Louis: Mosby, 1988:1496-580.
2. Jaanus SD. Drug therapy for ocular allergy. Optom Clin 1992;2:35-44.
3. Vanden Bussche G, Emanuel MB, Rombaut N. Clinical profile of astemizole. A survey of 50 double-blind trials. Ann Allergy 1987;58:184-8.
4. Lofrvist T, Agrell B, Dreborg S, Svensson G. Effects of immunotherapy with a purified standardized allergen preparation of Dermatophagoides farinae in adults with perennial allergic rhinoconjunctivitis. Allergy 1994;49:100-7.
5. Bartlett JD. Pharmacology of allergic eye disease. J Am Optom Assoc 1990;61(6 Suppl):23-31.
6. Tinkelman DG, Rupp G, Kaufman H, Pugely J, Schultz N. Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol 1993;38(Suppl):133-40.
7. Lanier BQ, Tremblay N, Smith JP, deFaller JM. A double-masked comparison of ocular decongestants as therapy for allergic conjunctivitis. Ann Allergy 1983;50:174-7.
8. Abelson MB, Paradis A, George MA, Smith LM, Maguire L, Burns R. Effects of Vasocon-A in the allergen challenge model of acute allergic conjunctivitis. Arch Ophthalmol 1990;108:520-4.
9. Fraunfelder FT, Meyer JM. Antihistamines. In: Fraunfelder FT, Meyer SM. Drug-induced ocular side effects and drug interactions. 3d ed. Baltimore: Williams & Wilkins, 1989.
10. Sorkin EM, Ward A. Ocular sodium cromoglycate. An overview of its therapeutic efficacy in allergic eye disease. Drugs 1986;31:131-48.
11. Johnson HG, VanHout CA, Wright JB. Inhibition of allergic reactions by cromoglycate and by a new anti-allergy drug U-42,585E. I. Activity in rats. Int Arch Allergy Appl Immunol 1978;56:416-23.
12. Caldwell DR, Verin P, Hartwich-Young R, Meyer SM, Drake MM. Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis. Am J Ophthalmol 1992;113:632-7.
13. Fahy GT, Easty DL, Collum LM, Benedict-Smith A, Hillery M, Parsons DC. Randomised double-masked trial of lodoxamide and sodium cromoglycate in allergic eye disease. A multicentre study. Eur J Opthalmol 1992;2:144-9.
14. Flach AJ. Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol 1992;36:259-84.
15. Ferreira SH, Nakamura M, de Abreu Castro MS. The hyperalgesic effects of prostacyclin and prostaglandin E2. Prostaglandins 1978;16.
16. Ballas Z, Blumenthal M, Tinkelman DG, Kriz R, Rupp G. Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol 1993;38(Suppl):141-8.
17. Package insert. Ketorolac. 1995.
18. Frostad AB, Olsen AK. A comparison of topical levocabastine and sodium cromoglycate in the treatment of pollen-provoked allergic conjunctivitis. Clin Exp Allergy 1993;23:406-9.
19. 1 antagonist in a conjunctival provocation test with allergens. J Allergy Clin Immunol 1988;82:590-4.
20. Sohoel P, Freng BA, Kramer J, Poppe S, Rebo R, Korsrud FR, et al. Topical levocabastine compared with orally administered terfenadine for the prophylaxis and treatment of seasonal rhinoconjunctivitis. J Allergy Clin Immunol 1993;92(1 Pt 1):73-81.
21. Dechant KL, Goa KL. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis. Drugs 1991;41:202-24.
22. Package insert. Levocabastine. 1995.